Skip to main content
Erschienen in: World Journal of Surgery 4/2017

21.11.2016 | Original Scientific Report

Hypertension Cure Following Laparoscopic Adrenalectomy for Hyperaldosteronism is not Universal: Trends Over Two Decades

verfasst von: Takeshi Namekawa, Takanobu Utsumi, Tomoaki Tanaka, Mayuko Kaga, Hidekazu Nagano, Takashi Kono, Koji Kawamura, Naoto Kamiya, Takashi Imamoto, Hiroyoshi Suzuki, Tomohiko Ichikawa

Erschienen in: World Journal of Surgery | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Laparoscopic adrenalectomy has been established as a standard surgical method for unilateral primary aldosteronism. Meanwhile, the background characteristics of the patients undergoing adrenalectomy have changed over the last 20 years. The aim of this study was to investigate the changes in hypertension cure rates after laparoscopic adrenalectomy during the last two decades.

Methods

This retrospective clinical study included 176 patients who underwent unilateral laparoscopic adrenalectomy for primary aldosteronism from 1995 to 2015. The patients were divided into two groups by decade. The patients’ baseline characteristics and the hypertension cure rates were compared between the two groups. Additionally, the values were re-examined based on predictive model predicting postoperative hypertension cure.

Results

The hypertension cure rate decreased significantly from 51.8 to 31.1%. The following variables were significantly different between the two groups: age, sex, body mass index, history of diabetes mellitus, preoperative systolic and diastolic blood pressures, potassium level, and plasma renin activity.

Conclusions

This study showed that the number of patients with unfavorable conditions for hypertension cure after adrenalectomy has recently increased. The treatment goal for primary aldosteronism is not only to cure the hypertension but also to prevent organ disorders due to inappropriate aldosterone levels. Therefore, we recommend laparoscopic adrenalectomy for unilateral primary aldosteronism, even if hypertension is not always cured postoperatively. However, clinicians need to fully explain the postoperative hypertension outcomes to primary aldosteronism patients.
Literatur
1.
Zurück zum Zitat Conn JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45:3–17PubMed Conn JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45:3–17PubMed
2.
Zurück zum Zitat Rossi E, Regolisti G, Negro A et al (2002) High prevalence of primary aldosteronism using post captopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15:896–902CrossRefPubMed Rossi E, Regolisti G, Negro A et al (2002) High prevalence of primary aldosteronism using post captopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15:896–902CrossRefPubMed
3.
Zurück zum Zitat Rossi GP, Seccia TM, Pessina AC (2007) Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Crit Rev Clin Lab Sci 44:1–85CrossRefPubMed Rossi GP, Seccia TM, Pessina AC (2007) Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Crit Rev Clin Lab Sci 44:1–85CrossRefPubMed
4.
Zurück zum Zitat Rossi GP, Bernini G, Caliumi C et al (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293–2300CrossRefPubMed Rossi GP, Bernini G, Caliumi C et al (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293–2300CrossRefPubMed
5.
Zurück zum Zitat Nishikawa T, Omura M, Satoh F et al (2011) Guidelines for the diagnosis and treatment of primary aldosteronism–the Japan Endocrine Society 2009. Endocr J 58:711–721CrossRefPubMed Nishikawa T, Omura M, Satoh F et al (2011) Guidelines for the diagnosis and treatment of primary aldosteronism–the Japan Endocrine Society 2009. Endocr J 58:711–721CrossRefPubMed
6.
Zurück zum Zitat Gagner M, Lacroix A, Bolté E (1992) Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 327:1033CrossRefPubMed Gagner M, Lacroix A, Bolté E (1992) Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 327:1033CrossRefPubMed
7.
Zurück zum Zitat Go H, Takeda M, Takahashi H et al (1993) Laparoscopic adrenalectomy for primary aldosteronism: a new operative method. J Laparosc Surg 3:455–459CrossRef Go H, Takeda M, Takahashi H et al (1993) Laparoscopic adrenalectomy for primary aldosteronism: a new operative method. J Laparosc Surg 3:455–459CrossRef
8.
9.
Zurück zum Zitat Utsumi T, Kawamura K, Imamoto T et al (2012) High predictive accuracy of aldosteronoma resolution score in Japanese patients with aldosterone-producing adenoma. Surgery 151:437–443CrossRefPubMed Utsumi T, Kawamura K, Imamoto T et al (2012) High predictive accuracy of aldosteronoma resolution score in Japanese patients with aldosterone-producing adenoma. Surgery 151:437–443CrossRefPubMed
10.
Zurück zum Zitat Utsumi T, Kawamura K, Imamoto T et al (2013) Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. Int J Urol 20:685–691CrossRefPubMed Utsumi T, Kawamura K, Imamoto T et al (2013) Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. Int J Urol 20:685–691CrossRefPubMed
11.
Zurück zum Zitat Utsumi T, Kamiya N, Endo T et al (2014) Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg 38:2640–2644. doi:10.1007/s00268-014-2612-1 CrossRefPubMed Utsumi T, Kamiya N, Endo T et al (2014) Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg 38:2640–2644. doi:10.​1007/​s00268-014-2612-1 CrossRefPubMed
12.
Zurück zum Zitat Utsumi T, Kawamura K, Imamoto T et al (2014) Assessment of postoperative changes in antihypertensive drug consumption in patients with primary aldosteronism using the defined daily dose. Asian J Surg 37:190–194CrossRefPubMed Utsumi T, Kawamura K, Imamoto T et al (2014) Assessment of postoperative changes in antihypertensive drug consumption in patients with primary aldosteronism using the defined daily dose. Asian J Surg 37:190–194CrossRefPubMed
14.
Zurück zum Zitat Steichen O, Zinzindohoué F, Plouin PF et al (2012) Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res 44:221–227CrossRefPubMed Steichen O, Zinzindohoué F, Plouin PF et al (2012) Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res 44:221–227CrossRefPubMed
15.
Zurück zum Zitat World Health Organization (1999) International Society of Hypertension Guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 17:151–183 World Health Organization (1999) International Society of Hypertension Guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 17:151–183
16.
Zurück zum Zitat Zarnegar R, Young WF Jr, Lee J et al (2008) The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247:511–518CrossRefPubMed Zarnegar R, Young WF Jr, Lee J et al (2008) The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247:511–518CrossRefPubMed
17.
Zurück zum Zitat Hiraishi K, Yoshimoto T, Tsuchiya K et al (2011) Clinicopathological features of primary aldosteronism associated with subclinical Cushing’s syndrome. Endocr J 58:543–551CrossRefPubMed Hiraishi K, Yoshimoto T, Tsuchiya K et al (2011) Clinicopathological features of primary aldosteronism associated with subclinical Cushing’s syndrome. Endocr J 58:543–551CrossRefPubMed
18.
Zurück zum Zitat Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed
19.
Zurück zum Zitat Funder JW, Carey RM, Mantero F et al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101:1889–1916CrossRefPubMed Funder JW, Carey RM, Mantero F et al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101:1889–1916CrossRefPubMed
20.
Zurück zum Zitat Ioachimescu AG, Remer EM, Hamrahian AH (2015) Adrenal incidentalomas: a disease of modern technology offering opportunities for improved patient care. Endocrinol Metab Clin North Am 44:335–354CrossRefPubMed Ioachimescu AG, Remer EM, Hamrahian AH (2015) Adrenal incidentalomas: a disease of modern technology offering opportunities for improved patient care. Endocrinol Metab Clin North Am 44:335–354CrossRefPubMed
21.
Zurück zum Zitat Omura M, Sasano H, Saito J et al (2006) Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29:883–889CrossRefPubMed Omura M, Sasano H, Saito J et al (2006) Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29:883–889CrossRefPubMed
22.
Zurück zum Zitat Rossi GP, Barisa M, Allolio B et al (2012) The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 97:1606–1614CrossRefPubMed Rossi GP, Barisa M, Allolio B et al (2012) The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 97:1606–1614CrossRefPubMed
23.
Zurück zum Zitat Muth A, Ragnarsson O, Johannsson G et al (2015) Systemic review of surgery and outcomes in patients with primary aldosteronism. Br J Surg 102:307–317CrossRefPubMed Muth A, Ragnarsson O, Johannsson G et al (2015) Systemic review of surgery and outcomes in patients with primary aldosteronism. Br J Surg 102:307–317CrossRefPubMed
24.
Zurück zum Zitat Nishikawa T, Omura M (2011) Should primary aldosteronism be diagnosed among normotensive subjects during general health check-up and/or at general outpatient clinics? Hypertens Res 34:47–48CrossRefPubMed Nishikawa T, Omura M (2011) Should primary aldosteronism be diagnosed among normotensive subjects during general health check-up and/or at general outpatient clinics? Hypertens Res 34:47–48CrossRefPubMed
25.
Zurück zum Zitat Born-Frontsberg E, Reincke M, Rump LC et al (2009) Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn’s Registry. J Clin Endocrinol Metab 94:1125–1130CrossRefPubMed Born-Frontsberg E, Reincke M, Rump LC et al (2009) Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn’s Registry. J Clin Endocrinol Metab 94:1125–1130CrossRefPubMed
26.
Zurück zum Zitat Catena C, Colussi G, Nadalini E et al (2007) Relationship of plasma renin levels with renal function in patients with primary aldosteronism. Clin J Am Soc Nephrol 2:722–731CrossRefPubMed Catena C, Colussi G, Nadalini E et al (2007) Relationship of plasma renin levels with renal function in patients with primary aldosteronism. Clin J Am Soc Nephrol 2:722–731CrossRefPubMed
27.
Zurück zum Zitat Rossi GP, Bolognesi M, Rizzoni D et al (2008) Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 51:1366–1371CrossRefPubMed Rossi GP, Bolognesi M, Rizzoni D et al (2008) Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 51:1366–1371CrossRefPubMed
28.
Zurück zum Zitat Wu VC, Chueh SC, Chang HW et al (2009) Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 54:665–673CrossRefPubMed Wu VC, Chueh SC, Chang HW et al (2009) Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 54:665–673CrossRefPubMed
Metadaten
Titel
Hypertension Cure Following Laparoscopic Adrenalectomy for Hyperaldosteronism is not Universal: Trends Over Two Decades
verfasst von
Takeshi Namekawa
Takanobu Utsumi
Tomoaki Tanaka
Mayuko Kaga
Hidekazu Nagano
Takashi Kono
Koji Kawamura
Naoto Kamiya
Takashi Imamoto
Hiroyoshi Suzuki
Tomohiko Ichikawa
Publikationsdatum
21.11.2016
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 4/2017
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3822-5

Weitere Artikel der Ausgabe 4/2017

World Journal of Surgery 4/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.